Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.6K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

250
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
250
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

509
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
509
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

155
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
155
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

249
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
249
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

120
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert perspectives on de-escalation of antiplatelet therapy - Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Transcatheter vs surgical aortic valve implantation: age vs lifetime perspective.

European heart journal·2026
Same author

On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT.

Journal of the American College of Cardiology·2026
Same author

Current Incidence and Modality of Young Aortic Valve Replacement in the United States.

Circulation·2026
Same author

Expert perspectives on tricuspid repair | replacement | medical therapy - Beyond the Guidelines: Insights from the cardiovascular research technologies 2026 meeting.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

M-TEER for Mitral Regurgitation: Does RESHAPE-HF2 Break the Tie or Muddy the Waters?

JACC. Cardiovascular interventions·2026

Related Experiment Video

Updated: Dec 10, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K

Lessons Learnt from Recent Trials in Ischemic Heart Disease.

John M Mandrola1, Sanjay Kaul2, Andrew Foy3

  • 1Department of Cardiology, Baptist Health Louisville, Louisville, Kentucky, United States.

Thrombosis and Haemostasis
|August 31, 2020
PubMed
Summary

Recent trials offer new insights for stable ischemic heart disease (SIHD) care. This review critically appraises this evidence to help clinicians apply findings in patient management.

More Related Videos

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

29.5K
A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
11:07

A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery

Published on: April 10, 2014

40.7K

Related Experiment Videos

Last Updated: Dec 10, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K
A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

29.5K
A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
11:07

A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery

Published on: April 10, 2014

40.7K

Area of Science:

  • Cardiology
  • Clinical Trials
  • Evidence-Based Medicine

Background:

  • Stable ischemic heart disease (SIHD) management relies on up-to-date clinical evidence.
  • Recent randomized controlled trials (RCTs) have emerged, impacting SIHD patient care.
  • Translating complex trial data into clinical practice presents a challenge.

Purpose of the Study:

  • To summarize and critically appraise recent RCTs relevant to SIHD.
  • To provide clinicians with actionable insights for integrating new evidence into patient care.
  • To enhance the application of evidence-based medicine in cardiology.

Main Methods:

  • Systematic review of four recent randomized controlled trials.
  • Critical appraisal of trial methodologies and results.
  • Synthesis of findings for clinical relevance in SIHD.

Main Results:

  • Summaries of key findings from four major RCTs in SIHD.
  • Appraisal of the quality and applicability of the evidence presented.
  • Identification of areas where trial results may alter current clinical practice.

Conclusions:

  • Recent RCTs provide significant updates for managing SIHD.
  • Clinicians should consider this evidence for optimizing patient treatment strategies.
  • Effective translation of research findings is crucial for improving SIHD outcomes.